Genomics of rapid adaptation to antibiotics: Convergent evolution and scalable sequence amplification

Genome Biology and Evolution

Volumn 6, Issue 6, 2014, Pages 1287-1301

  Laehnemann, David ^a   Peña Miller, Rafael ^b,c   Rosenstiel, Philip ^a   Beardmore, Robert ^b   Jansen, Gunther ^a   Schulenburg, Hinrich ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibiotic resistance; Escherichia coli; Experimental evolution; MC4100; Population genomics; Synonymous codon

Indexed keywords

ANTIINFECTIVE AGENT; CODON; ESCHERICHIA COLI PROTEIN;

ADAPTATION; ANTIBIOTIC RESISTANCE; BACTERIAL GENOME; CODON; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; MICROBIOLOGY; MOLECULAR EVOLUTION; MUTATION;

ADAPTATION, PHYSIOLOGICAL; ANTI-BACTERIAL AGENTS; CODON; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; HUMANS; MUTATION;

EID: 84902997865     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evu106     Document Type: Article

References (126)

1. Accardi A, Miller C. 2004. Secondary active transport mediated by a prokaryotic homologue of ClC Cl- channels. Nature 427(6977): 803-807.
2. Adams MA, Jia Z. 2005. Structural and biochemical evidence for an enzymatic quinone redox cycle in Escherichia coli: identification of a novel quinol monooxygenase. J Biol Chem. 280(9): 8358-8363.
3. Adler M, Anjum M, Berg OG, Andersson DI, Sandegren L. 2014. High fitness costs and instability of gene duplications reduce rates of evolution of new genes by duplication-divergence mechanisms. Mol Biol Evol. 31(6): 1526-1535.
4. Adzhubei IA, et al. 2010. A method and server for predicting damaging missense mutations. Nat Methods. 7(4): 248-249.
5. Alekshun MN, Levy SB. 2007. Molecular mechanisms of antibacterial multidrug resistance. Cell 128(6): 1037-1050.
6. Anderson P, Roth J. 1981. Spontaneous tandem genetic duplications in Salmonella typhimurium arise by unequal recombination between rRNA (rrn) cistrons. Proc Natl Acad Sci U S A. 78(5): 3113-3117.
7. Andersson DI, Hughes D. 2009. Gene amplification and adaptive evolution in bacteria. Annu Rev Genet. 43: 167-195.
8. Arendt J, Reznick D. 2008. Convergence and parallelism reconsidered: what have we learned about the genetics of adaptation? Trends Ecol Evol. 23(1): 26-32.
9. Barbosa TM, Levy SB. 2000. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol. 182(12): 3467-3474.
10. Bentley R, Meganathan R. 1982. Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol Rev. 46(3): 241-280.
11. Bessman MJ, Frick DN, O'Handley SF. 1996. TheMutT proteins or "Nudix" hydrolases, a family of versatile, widely distributed, "housecleaning" enzymes. J Biol Chem. 271(41): 25059-25062.
12. Blair JMA, Piddock LJV. 2009. Structure, function and inhibition of RND efflux pumps in gram-negative bacteria: an update. Curr Opin Microbiol. 12(5): 512-519.
13. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. 2000. Role of quinones in toxicology. Chem Res Toxicol. 13(3): 135-160.
14. Bonfield JK, Whitwham A. 2010. Gap5 - editing the billion fragment sequence assembly. Bioinformatics 26(14): 1699-1703.
15. Burstein C, Kepes A. 1971. The alpha-galactosidase from Escherichia coli K12. Biochim Biophys Acta. 230(1): 52-63.
16. Cannon RD, et al. 2009. Efflux-mediated antifungal drug resistance. Clin Microbiol Rev. 22(2): 291-321; Table of Contents.
17. Chao L, Vargas C, Spear BB, Cox EC. 1983. Transposable elements as mutator genes in evolution. Nature 303(5918): 633-635.
18. Christin PA, Weinreich DM, Besnard G. 2010. Causes and evolutionary significance of genetic convergence. Trends Genet. 26(9): 400-405.
19. Cox MM. 2007. Regulation of bacterial RecA protein function. Crit Rev Biochem Mol Biol. 42(1): 41-63.
20. Dettman JR, et al. 2012. Evolutionary insight from whole-genome sequencing of experimentally evolved microbes. Mol Ecol. 21(9): 2058-2077.
21. DiFrancesco R, Bhatnagar SK, Brown A, Bessman MJ. 1984. The interaction of DNA polymerase III and the product of the Escherichia coli mutator gene, mutD. J Biol Chem. 259(9): 5567-5573.
22. den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat. 15(1): 7-12.
23. Edwards KJ, Thorn JM, Daniher JA, Dixon NE, Ollis DL. 1994. Crystallization and preliminary X-ray diffraction studies on a soluble Escherichia coli quinone oxidoreductase. J Mol Biol. 240(5): 501-503.
24. Eicher T, Brandstätter L, Pos KM. 2009. Structural and functional aspects of the multidrug efflux pump AcrB. Biol Chem. 390(8): 693-699.
25. Elkins CA, Nikaido H. 2002. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominately by two large periplasmic loops. J Bacteriol. 184(23): 6490-6498.
26. Ferenci T, et al. 2009. Genomic sequencing reveals regulatory mutations and recombinational events in the widely used MC4100 lineage of Escherichia coli K-12. J Bacteriol. 191(12): 4025-4029.
27. Frick DN, Bessman MJ. 1995. Cloning, purification, and properties of a novel NADH pyrophosphatase. Evidence for a nucleotide pyrophosphatase catalytic domain in MutT-like enzymes. J Biol Chem. 270(4): 1529-1534.
28. Galhardo RS, Hastings PJ, Rosenberg SM. 2007. Mutation as a stress response and the regulation of evolvability. Crit Rev Biochem Mol Biol. 42(5): 399-435.
29. Gillet JP, Efferth T, Remacle J. 2007. Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta. 1775(2): 237-262.
30. Gonzalez CF, et al. 2006. Molecular basis of formaldehyde detoxification. characterization of two S-formylglutathione hydrolases from Escherichia coli, FrmB and YeiG. J Biol Chem. 281(20): 14514-14522.
31. Gutheil WG, Holmquist B, Vallee BL. 1992. Purification, characterization, and partial sequence of the glutathione-dependent formaldehyde dehydrogenase from Escherichia coli: a class III alcohol dehydrogenase. Biochemistry 31(2): 475-481.
32. Hanatani M, et al. 1984. Physical and genetic characterization of the melibiose operon and identification of the gene products in Escherichia coli. J Biol Chem. 259(3): 1807-1812.
33. Harris DR, et al. 2009. Directed evolution of ionizing radiation resistance in Escherichia coli. J Bacteriol. 191(16): 5240-5252.
34. Hastings PJ, Lupski JR, Rosenberg SM, Ira G. 2009. Mechanisms of change in gene copy number. Nat Rev Genet. 10(8): 551-564.
35. Hayashi M, Ohzeki H, Shimada H, Unemoto T. 1996. NADPH-specific quinone reductase is induced by 2-methylene-4-butyrolactone in Escherichia coli. Biochim Biophys Acta. 1273(2): 165-170.
36. Hegreness M, Kishony R. 2007. Analysis of genetic systems using experimental evolution and whole-genome sequencing. Genome Biol. 8(1): 201.
37. Hegreness M, Shoresh N, Damian D, Hartl D, Kishony R. 2008. Accelerated evolution of resistance in multidrug environments. Proc Natl Acad Sci U S A. 105(37): 13977-13981.
38. Herring CD, Blattner FR. 2004. Global transcriptional effects of a suppressor tRNA and the inactivation of the regulator frmR. J Bacteriol. 186(20): 6714-6720.
39. Higgins MK, Bokma E, Koronakis E, Hughes C, Koronakis V. 2004. Structure of the periplasmic component of a bacterial drug efflux pump. Proc Natl Acad Sci U S A. 101(27): 9994-9999.
40. Ikeuchi Y, Kitahara K, Suzuki T. 2008. The RNA acetyltransferase driven by ATP hydrolysis synthesizes N4-acetylcytidine of tRNA anticodon. EMBO J. 27(16): 2194-2203.
41. Iyer R, Iverson TM, Accardi A, Miller C. 2002. A biological role for prokaryotic ClC chloride channels. Nature 419(6908): 715-718.
42. Jacoby GA. 2009. History of drug-resistant microbes. In: Mayers DL, Georgiev VS, editors. Antimicrobial drug resistance, infectious disease. New York: Humana Press. p. 3-7.
43. Kato J, Nishimura Y, Yamada M, Suzuki H, Hirota Y. 1988. Gene organization in the region containing a new gene involved in chromosome partition in Escherichia coli. J Bacteriol. 170(9): 3967-3977.
44. Kawecki TJ, et al. 2012. Experimental evolution. Trends Ecol Evol. 27(10): 547-560.
45. Keseler IM, et al. 2011. EcoCyc: a comprehensive database of Escherichia coli biology. Nucleic Acids Res. 39(Database issue):D583-D590.
46. Khil PP, Camerini-Otero RD. 2002. Over 1000 genes are involved in the DNA damage response of Escherichia coli. Mol Microbiol. 44(1): 89-105.
47. Koboldt DC, et al. 2012. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22(3): 568-576.
48. Kolodner R, Fishel RA, Howard M. 1985. Genetic recombination of bacterial plasmid DNA: effect of RecF pathway mutations on plasmid recombination in Escherichia coli. J Bacteriol. 163(3): 1060-1066.
49. Kuznetsova E, et al. 2006. Genome-wide analysis of substrate specificities of the Escherichia coli haloacid dehalogenase-like phosphatase family. J Biol Chem. 281(47): 36149-36161.
50. LeClerc JE, Li B, Payne WL, Cebula TA. 1996. High mutation frequencies among Escherichia coli and salmonella pathogens. Science 274(5290): 1208-1211.
51. Lenski RE, Levin BR. 1985. Constraints on the coevolution of bacteria and virulent phage - a model, some experiments, and predictions for natural communities. Am Nat. 125(4): 585-602.
52. Li M, et al. 2007. Crystal structure of the transcriptional regulator AcrR from Escherichia coli. J Mol Biol. 374(3): 591-603.
53. Lilley PE, Stamford NP, Vasudevan SG, Dixon NE. 1993. The 92-min region of the Escherichia coli chromosome: location and cloning of the ubiA and alr genes. Gene 129(1): 9-16.
54. Lindgren PK, Karlsson A, Hughes D. 2003. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother. 47(10): 3222-3232.
55. Liu T, et al. 2007. CsoR is a novel Mycobacterium tuberculosis coppersensing transcriptional regulator. Nat Chem Biol. 3(1): 60-68.
56. Losos JB. 2011. Convergence, adaptation, and constraint. Evolution 65(7): 1827-1840.
57. Lovett ST. 2004. Encoded errors: mutations and rearrangementsmediated by misalignment at repetitive DNA sequences. Mol Microbiol. 52(5): 1243-1253.
58. Ma D, Alberti M, Lynch C, Nikaido H, Hearst JE. 1996. The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol Microbiol. 19(1): 101-112.
59. Ma D, et al. 1993.Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol. 175(19): 6299-6313.
60. Ma D, et al. 1995. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol. 16(1): 45-55.
61. MacLean RC, Hall AR, Perron GG, Buckling A. 2010. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat Rev Genet. 11(6): 405-414.
62. MacLean RC, Torres-Barceló C, Moxon R. 2013. Evaluating evolutionary models of stress-induced mutagenesis in bacteria. Nat Rev Genet. 14(3): 221-227.
63. Maneewannakul K, Levy SB. 1996. Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother. 40(7): 1695-1698.
64. Matic I, et al. 1997. Highly variable mutation rates in commensal and pathogenic Escherichia coli. Science 277(5333): 1833-1834.
65. McLennan AG. 2006. The Nudix hydrolase superfamily. Cell Mol Life Sci. 63(2): 123-143.
66. Mikolosko J, Bobyk K, Zgurskaya HI, Ghosh P. 2006. Conformational flexibility in the multidrug efflux system protein AcrA. Structure 14(3): 577-587.
67. Morrison PT, Lovett ST, Gilson LE, Kolodner R. 1989. Molecular analysis of the Escherichia coli recO gene. J Bacteriol. 171(7): 3641-3649.
68. Mott ML, Berger JM. 2007. DNA replication initiation: mechanisms and regulation in bacteria. Nat Rev Microbiol. 5(5): 343-354.
69. Nagao Y, et al. 1988. Purification and analysis of the structure of alphagalactosidase from Escherichia coli. Biochem Biophys Res Commun. 151(1): 236-241.
70. Newton NA, Cox GB, Gibson F. 1971. The function of menaquinone (vitamin K 2) in Escherichia coli K-12. Biochim Biophys Acta. 244(1): 155-166.
71. Nicoloff H, Andersson DI. 2013. Lon protease inactivation, or translocation of the lon gene, potentiate bacterial evolution to antibiotic resistance. Mol Microbiol. 90: 1233-1248.
72. Nicoloff H, Perreten V, Levy SB. 2007. Increased genome instability in Escherichia coli lon mutants: relation to emergence of multipleantibiotic- resistant (Mar) mutants caused by IS elements and large tandem genomic amplifications. Antimicrob Agents Chemother. 51(4): 1293-1303.
73. Nicoloff H, Perreten V, McMurry LM, Levy SB. 2006. Role for tandem duplication and lon protease in AcrAB-TolC-dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB. J Bacteriol. 188(12): 4413-4423.
74. Nikaido H, Takatsuka Y. 2009. Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta. 1794(5): 769-781.
75. Nishino K, Yamaguchi A. 2001. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol. 183(20): 5803-5812.
76. Oliver A, Cantón R, Campo P, Baquero F, Blázquez J. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288(5469): 1251-1254.
77. Palmer DR, et al. 1999. Unexpected divergence of enzyme function and sequence: "N-acylamino acid racemase" is o-succinylbenzoate synthase. Biochemistry 38(14): 4252-4258.
78. Palumbi SR. 2001. Humans as the world's greatest evolutionary force. Science 293(5536): 1786-1790.
79. Partridge JD, et al. 2008. Characterization of the Escherichia coli K-12 ydhYVWXUT operon: regulation by FNR, NarL and NarP. Microbiology 154(Pt 2): 608-618.
80. Peña-Miller R, et al. 2013. When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition. PLoS Biol. 11(4):e1001540.
81. Plotkin JB, Kudla G. 2011. Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet. 12(1): 32-42.
82. Proudfoot M, et al. 2004. General enzymatic screens identify three new nucleotidases in Escherichia coli. biochemical characterization of SurE, YfbR, and YjjG. J Biol Chem. 279(52): 54687-54694.
83. Reed JL, Vo TD, Schilling CH, Palsson BO. 2003. An expanded genomescale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol. 4(9):R54.
84. Reizer J, Reizer A, Saier MH. 1994. A functional superfamily of sodium/solute symporters. Biochim Biophys Acta. 1197(2): 133-166.
85. Rodrigue A, Effantin G, Mandrand-Berthelot MA. 2005. Identification of rcnA (yohM), a nickel and cobalt resistance gene in Escherichia coli. J Bacteriol. 187(8): 2912-2916.
86. Ross D. 2004. Quinone reductases multitasking in the metabolic world. Drug Metab Rev. 36(3-4): 639-654.
87. Roth JR, et al. 1996. Escherichia coli and Salmonella typhimurium: cellular and molecular biology, 2nd ed. Chapter rearrangements of the bacterial chromosome: formation and applications. Washington (DC): American Society for Microbiology. p. 2256-2276.
88. Routh MD, Su CC, Zhang Q, Yu EW. 2009. Structures of AcrR and CmeR: insight into the mechanisms of transcriptional repression and multidrug recognition in the TetR family of regulators. Biochim Biophys Acta. 1794(5): 844-851.
89. Samaluru H, SaiSree L, Reddy M. 2007. Role of SufI (FtsP) in cell division of Escherichia coli: evidence for its involvement in stabilizing the assembly of the divisome. J Bacteriol. 189(22): 8044-8052.
90. Sampaio MM, et al. 2004. Phosphotransferase-mediated transport of the osmolyte 2-o-alpha-mannosyl-d-glycerate in Escherichia coli occurs by the product of the mngA (hrsA) gene and is regulated by the mngR (farR) gene product acting as repressor. J Biol Chem. 279(7): 5537-5548.
91. Sanchez CP, Dave A, SteinWD, Lanzer M. 2010. Transporters as mediators of drug resistance in Plasmodium falciparum. Int J Parasitol. 40(10): 1109-1118.
92. Sandegren L, Andersson DI. 2009. Bacterial gene amplification: implications for the evolution of antibiotic resistance. Nat Rev Microbiol. 7(8): 578-588.
93. Schenk MF, Szendro IG, Krug J, de Visser JAGM. 2012. Quantifying the adaptive potential of an antibiotic resistance enzyme. PLoS Genet. 8(6):e1002783.
94. Scheuermann R, Tam S, Burgers PM, Lu C, Echols H. 1983. Identification of the epsilon-subunit of Escherichia coli DNA polymerase III holoenzyme as the dnaQ gene product: a fidelity subunit for DNA replication. Proc Natl Acad Sci U S A. 80(23): 7085-7089.
95. Schmitt R. 1968. Analysis of melibiose mutants deficient in alpha-galactosidase and thiomethylgalactoside permease II in Escherichia coli K-12. J Bacteriol. 96(2): 462-471.
96. Selmecki A, Gerami-Nejad M, Paulson C, Forche A, Berman J. 2008. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol Microbiol. 68(3): 624-641.
97. Seoane AS, Levy SB. 1995. Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. J Bacteriol. 177(12): 3414-3419.
98. Serres MH, et al. 2001. A functional update of the Escherichia coli K-12 genome. Genome Biol. 2(9)RESEARCH0035.
99. Shabalina SA, Spiridonov NA, Kashina A. 2013. Sounds of silence: synonymous nucleotides as a key to biological regulation and complexity. Nucleic Acids Res. 41(4): 2073-2094.
100. Sharma V, Meganathan R, Hudspeth ME. 1993. Menaquinone (vitamin K2) biosynthesis: cloning, nucleotide sequence, and expression of the menC gene from Escherichia coli. J Bacteriol. 175(15): 4917-4921.
101. Siguier P, Filée J, Chandler M. 2006. Insertion sequences in prokaryotic genomes. Curr Opin Microbiol. 9(5): 526-531.
102. Sniegowski PD, Gerrish PJ, Lenski RE. 1997. Evolution of highmutation rates in experimental populations of E. coli. Nature 387(6634): 703-705.
103. Stapley J, et al. 2010. Adaptation genomics: the next generation. Trends Ecol Evol. 25(12): 705-712.
104. Su CC, Rutherford DJ, Yu EW. 2007. Characterization of the multidrug efflux regulator AcrR from Escherichia coli. Biochem Biophys Res Commun. 361(1): 85-90.
105. Sulavik MC, et al. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother. 45(4): 1126-1136.
106. Symmons MF, Bokma E, Koronakis E, Hughes C, Koronakis V. 2009. The assembled structure of a complete tripartite bacterial multidrug efflux pump. Proc Natl Acad Sci U S A. 106(17): 7173-7178.
107. Taddei F, et al. 1997. Role of mutator alleles in adaptive evolution. Nature 387(6634): 700-702.
108. Tenaillon O, Denamur E, Matic I. 2004. Evolutionary significance of stressinduced mutagenesis in bacteria. Trends Microbiol. 12(6): 264-270.
109. Tenaillon O, et al. 2012. The molecular diversity of adaptive convergence. Science 335(6067): 457-461.
110. Thompson TB, et al. 2000. Evolution of enzymatic activity in the enolase superfamily: structure of o-succinylbenzoate synthase from Escherichia coli in complex with Mg2+ and o-succinylbenzoate. Biochemistry 39(35): 10662-10676.
111. Thorn JM, Barton JD, Dixon NE, Ollis DL, Edwards KJ. 1995. Crystal structure of Escherichia coli QOR quinone oxidoreductase complexed with NADPH. J Mol Biol. 249(4): 785-799.
112. Titz B, Häuser R, Engelbrecher A, Uetz P. 2007. The Escherichia coli protein YjjG is a house-cleaning nucleotidase in vivo. FEMS Microbiol Lett. 270(1): 49-57.
113. Toprak E, et al. 2011. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet. 44(1): 101-105.
114. Wake DB, Wake MH, Specht CD. 2011. Homoplasy: from detecting pattern to determining process and mechanism of evolution. Science 331(6020): 1032-1035.
115. Walsh C. 2000. Molecular mechanisms that confer antibacterial drug resistance. Nature 406(6797): 775-781.
116. Walsh C. 2003. Antibiotics: actions, origins, resistance. Washington (DC): ASM Press.
117. Wang H, Dzink-Fox JL, Chen M, Levy SB. 2001. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother. 45(5): 1515-1521.
118. Webber MA, Piddock LJ. 2001. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob Agents Chemother. 45(5): 1550-1552.
119. Wei Z, Wang W, Hu P, Lyon GJ, Hakonarson H. 2011. SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data. Nucleic Acids Res. 39(19):e132.
120. Wilson DM, Wilson TH. 1987. Cation specificity for sugar substrates of the melibiose carrier in Escherichia coli. Biochim Biophys Acta. 904(2): 191-200.
121. Wilson TH, Ding PZ. 2001. Sodium-substrate cotransport in bacteria. Biochim Biophys Acta. 1505(1): 121-130.
122. Wu TH, Clarke CH, Marinus MG. 1990. Specificity of Escherichia colimutD and mutL mutator strains. Gene 87(1): 1-5.
123. Yazyu H, et al. 1984. Nucleotide sequence of the melB gene and characteristics of deduced amino acid sequence of the melibiose carrier in Escherichia coli. J Biol Chem. 259(7): 4320-4326.
124. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z. 2009. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25(21): 2865-2871.
125. Zgurskaya HI, Nikaido H. 1999. AcrA is a highly asymmetric protein capable of spanning the periplasm. J Mol Biol. 285(1): 409-420.
126. Zgurskaya HI, Nikaido H. 2000. Cross-linked complex between oligomeric periplasmic lipoprotein AcrA and the inner-membrane-associated multidrug efflux pump AcrB from Escherichia coli. J Bacteriol. 182(15): 4264-4267.